GB0506708D0 - Use of calcitonin as combined treatment therapy for the management of inflammatory disease conditions - Google Patents
Use of calcitonin as combined treatment therapy for the management of inflammatory disease conditionsInfo
- Publication number
- GB0506708D0 GB0506708D0 GBGB0506708.7A GB0506708A GB0506708D0 GB 0506708 D0 GB0506708 D0 GB 0506708D0 GB 0506708 A GB0506708 A GB 0506708A GB 0506708 D0 GB0506708 D0 GB 0506708D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- calcitonin
- management
- inflammatory disease
- combined treatment
- disease conditions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 102000055006 Calcitonin Human genes 0.000 title 1
- 108060001064 Calcitonin Proteins 0.000 title 1
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 title 1
- 229960004015 calcitonin Drugs 0.000 title 1
- 208000027866 inflammatory disease Diseases 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Transplantation (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Dermatology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Priority Applications (14)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0506708.7A GB0506708D0 (en) | 2005-04-01 | 2005-04-01 | Use of calcitonin as combined treatment therapy for the management of inflammatory disease conditions |
| CNA2006800137667A CN101180070A (zh) | 2005-04-01 | 2006-03-30 | 降钙素在治疗炎性疾病状况中作为组合治疗的应用 |
| AU2006228334A AU2006228334A1 (en) | 2005-04-01 | 2006-03-30 | Use of calcitonin as combined treatment therapy for the management of inflammatory disease conditions |
| PCT/GB2006/001183 WO2006103455A2 (en) | 2005-04-01 | 2006-03-30 | Use of calcitonin as combined treatment therapy for the management of inflammatory disease conditions |
| BRPI0612220-5A BRPI0612220A2 (pt) | 2005-04-01 | 2006-03-30 | composição farmacêutica, uso de uma calcitonina e um glucocorticóide, kit de partes que compreendem uma calcitonina e um glucocorticóide e kit de partes que compreendem uma calcitonina, um glucocorticóide e uma droga anti-reumática |
| MX2007012078A MX2007012078A (es) | 2005-04-01 | 2006-03-30 | Uso de calcitonina como terapia de tratamiento combinado para el manejo de condiciones de enfermedad inflamatoria. |
| EP06726589.2A EP1868627B1 (en) | 2005-04-01 | 2006-03-30 | Use of calcitonin as combined treatment therapy for the management of inflammatory disease conditions |
| US11/910,023 US20080160025A1 (en) | 2005-04-01 | 2006-03-30 | Use of Calcitonin as Combined Treatment Therapy for the Management of Inflammatory Disease Conditions |
| JP2008503594A JP2008534566A (ja) | 2005-04-01 | 2006-03-30 | 炎症性疾患状態の処理のための併用治療療法としてのカルシトニンの使用 |
| KR1020077025348A KR20080017001A (ko) | 2005-04-01 | 2006-03-30 | 염증성 질환의 관리를 위한 병합 치료 요법으로서칼시토닌의 용도 |
| RU2007139888/15A RU2394591C2 (ru) | 2005-04-01 | 2006-03-30 | Применение кальцитонина в качестве комбинированной терапии для лечения воспалительных болезненных состояний |
| CA002603156A CA2603156A1 (en) | 2005-04-01 | 2006-03-30 | Use of calcitonin as combined treatment therapy for the management of inflammatory disease conditions |
| IL186286A IL186286A0 (en) | 2005-04-01 | 2007-09-25 | Use of calcitonin as combined treatment therapy for the management of inflammatory disease conditions |
| JP2012201476A JP2013032360A (ja) | 2005-04-01 | 2012-09-13 | 炎症性疾患状態の処理のための併用治療療法としてのカルシトニンの使用 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0506708.7A GB0506708D0 (en) | 2005-04-01 | 2005-04-01 | Use of calcitonin as combined treatment therapy for the management of inflammatory disease conditions |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB0506708D0 true GB0506708D0 (en) | 2005-05-11 |
Family
ID=34586589
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB0506708.7A Ceased GB0506708D0 (en) | 2005-04-01 | 2005-04-01 | Use of calcitonin as combined treatment therapy for the management of inflammatory disease conditions |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20080160025A1 (enExample) |
| EP (1) | EP1868627B1 (enExample) |
| JP (2) | JP2008534566A (enExample) |
| KR (1) | KR20080017001A (enExample) |
| CN (1) | CN101180070A (enExample) |
| AU (1) | AU2006228334A1 (enExample) |
| BR (1) | BRPI0612220A2 (enExample) |
| CA (1) | CA2603156A1 (enExample) |
| GB (1) | GB0506708D0 (enExample) |
| IL (1) | IL186286A0 (enExample) |
| MX (1) | MX2007012078A (enExample) |
| RU (1) | RU2394591C2 (enExample) |
| WO (1) | WO2006103455A2 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012040364A1 (en) | 2010-09-21 | 2012-03-29 | Unigene Laboratories Inc. | Calcitonin products and therapies for treating inflammatory or degenerative diseases |
| UY34105A (es) | 2011-06-03 | 2012-07-31 | Lg Life Sciences Ltd | Formulación líquida estable de etanercept |
| US9616081B2 (en) * | 2013-03-27 | 2017-04-11 | Taiho Pharmaceutical Co., Ltd. | Antitumor agent including low-dose irinotecan hydrochloride hydrate |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4006269A1 (de) * | 1990-02-28 | 1991-08-29 | Max Planck Gesellschaft | Antikoerper gegen den tumor-nekrosefaktor-rezeptor |
| UA41909C2 (uk) * | 1994-07-22 | 2001-10-15 | Елі Ліллі Енд Компані | Використання комбінації сполук для інгібірування остеопорозу, фармацевтичний препарат |
| WO2001013957A2 (en) * | 1999-08-24 | 2001-03-01 | Cellgate, Inc. | Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties |
| US20060002935A1 (en) * | 2002-06-28 | 2006-01-05 | Domantis Limited | Tumor Necrosis Factor Receptor 1 antagonists and methods of use therefor |
| WO2005009949A2 (en) * | 2003-06-30 | 2005-02-03 | Merck & Co., Inc. | 17-acetamido-4-azasteroid derivatives as androgen receptor modulators |
-
2005
- 2005-04-01 GB GBGB0506708.7A patent/GB0506708D0/en not_active Ceased
-
2006
- 2006-03-30 JP JP2008503594A patent/JP2008534566A/ja not_active Withdrawn
- 2006-03-30 US US11/910,023 patent/US20080160025A1/en not_active Abandoned
- 2006-03-30 EP EP06726589.2A patent/EP1868627B1/en not_active Expired - Lifetime
- 2006-03-30 BR BRPI0612220-5A patent/BRPI0612220A2/pt not_active IP Right Cessation
- 2006-03-30 AU AU2006228334A patent/AU2006228334A1/en not_active Abandoned
- 2006-03-30 CA CA002603156A patent/CA2603156A1/en not_active Abandoned
- 2006-03-30 RU RU2007139888/15A patent/RU2394591C2/ru not_active IP Right Cessation
- 2006-03-30 MX MX2007012078A patent/MX2007012078A/es active IP Right Grant
- 2006-03-30 CN CNA2006800137667A patent/CN101180070A/zh active Pending
- 2006-03-30 KR KR1020077025348A patent/KR20080017001A/ko not_active Ceased
- 2006-03-30 WO PCT/GB2006/001183 patent/WO2006103455A2/en not_active Ceased
-
2007
- 2007-09-25 IL IL186286A patent/IL186286A0/en unknown
-
2012
- 2012-09-13 JP JP2012201476A patent/JP2013032360A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA2603156A1 (en) | 2006-10-05 |
| JP2013032360A (ja) | 2013-02-14 |
| JP2008534566A (ja) | 2008-08-28 |
| BRPI0612220A2 (pt) | 2010-10-26 |
| RU2394591C2 (ru) | 2010-07-20 |
| MX2007012078A (es) | 2008-02-22 |
| EP1868627A2 (en) | 2007-12-26 |
| CN101180070A (zh) | 2008-05-14 |
| WO2006103455A3 (en) | 2007-03-01 |
| KR20080017001A (ko) | 2008-02-25 |
| WO2006103455A2 (en) | 2006-10-05 |
| US20080160025A1 (en) | 2008-07-03 |
| EP1868627B1 (en) | 2014-10-15 |
| RU2007139888A (ru) | 2009-05-10 |
| AU2006228334A1 (en) | 2006-10-05 |
| IL186286A0 (en) | 2008-01-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL186749A0 (en) | Dihydrothienopyrimidines for the treatment of inflammatory diseases | |
| ZA200808178B (en) | Imidazolothiazole compounds for the treatment of disease | |
| EP1976377A4 (en) | COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS | |
| ZA200803440B (en) | Compounds for the treatment of metabolic disorders | |
| EP1983972A4 (en) | COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS | |
| IL195203A0 (en) | Compounds for the treatment of metabolic disorders | |
| IL181049A0 (en) | Biphenyloxyacetic acid derivatives for the treatment of respiratory disease | |
| IL192852A0 (en) | Compounds for the treatment of metabolic disorders | |
| IL200091A0 (en) | Use of chitosans for the treatment of nail inflammatory diseases | |
| GB0410399D0 (en) | The treatment of respiratory disease | |
| GB0700972D0 (en) | Treatment of inflammatory disease | |
| IL178815A0 (en) | The treatment of respiratory disease | |
| GB0720976D0 (en) | Treatment of inflammatory disease | |
| PL1945243T3 (pl) | Zastosowanie kalcytoniny w leczeniu rzs | |
| IL195392A0 (en) | Compounds for the treatment of metabolic disorders | |
| IL192851A0 (en) | Compounds for the treatment of metabolic disorders | |
| IL186286A0 (en) | Use of calcitonin as combined treatment therapy for the management of inflammatory disease conditions | |
| GB0400802D0 (en) | Compounds for the treatment of disease | |
| GB0428218D0 (en) | Medicament for Treatment of Inflammatory Diseases | |
| ZA200606780B (en) | Compounds for the treatment of diseases | |
| IL192982A0 (en) | Compounds for the treatment of metabolic disorders | |
| GB0411301D0 (en) | Treatment of inflammatory disease | |
| GB0415352D0 (en) | Compounds for the treatment of disease | |
| IL177531A0 (en) | Compounds for the treatment of diseases | |
| GB0420867D0 (en) | Compounds for the treatment of diseases |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |